orthodontic pain. Disorder of teeth and supporting structures, unspecified
Conditions
Interventions
Intervention 1: In drug group patients receive 400mg Gelofen an hour before placing separator between the contacts of maxillary molars and after placement using laser facade flash without therapeut
Treatment - Drugs
Treatment - Other
In drug group patients receive 400mg Gelofen an hour before placing separator between the contacts of maxillary molars and after placement using laser facade flash without therapeutic effect .
In the laser group patients receive placebo of the Gelofen an hours before placement of separator between the contacts of maxillary molars.Immediately after separator placement laser will expose to
Sponsors
Vice Chancellor for Research and Technology, Hamedan University of Medical Science
Eligibility
Sex/Gender
All
Age
13 Years to 25 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients between13-25 years old;Female patients not to be pregnant; Patients with no orthodontic treatment history; Patients with no gelofen reaction history in the drug group; In the drug group the minimum weight should be 40 kg. Exclusion criteria: patients with history of systemic disease; Patients with periodontal disease, More than 3 mm Probing depth; Attached gingiva recession; Using antibiotic in drug group .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The pain after seprator placement. Timepoint: Immediately after the intervention, 6 hours after intervention, 12 hours after intervention, 24 hours after intervention,2 days after intervention,3 days or more after intervention. Method of measurement: Questionnaire Modified McGill. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactvahid mollabashi
Hamedan University of Medical Sciences
Outcome results
None listed